Table 2 Logistic regression analysis of “any-ROSC” associated with ESKD and other variables in OHCA patients.
Unadjusted model | †Adjusted model | |||||
---|---|---|---|---|---|---|
OR | 95% CI | P value | Adjusted OR | 95% CI | P value | |
ESKD (Yes) | 2.63 | 1.74, 4.11 | < 0.01* | 4.82 | 2.70, 8.95 | < 0.01* |
Sex (Male) | 0.95 | 0.74, 1.22 | 0.70 | 0.92 | 0.67, 1.26 | 0.59 |
Age | 0.99 | 0.99, 1.00 | 0.03* | 0.99 | 0.98, 1 | < 0.01* |
Baseline comorbidities | ||||||
HTN | 0.97 | 0.72, 1.31 | 0.82 | 0.81 | 0.53, 1.23 | 0.32 |
DM | 1.05 | 0.81, 1.37 | 0.70 | 1.03 | 0.73, 1.46 | 0.85 |
COPD | 1.06 | 0.81, 1.39 | 0.69 | 1.04 | 0.72, 1.52 | 0.83 |
CLD | 1.52 | 0.96, 2.48 | 0.09 | 1.32 | 0.75, 2.38 | 0.34 |
CKD | 0.84 | 0.64, 1.12 | 0.24 | 1.32 | 0.89, 1.95 | 0.16 |
PAOD | 0.64 | 0.38, 1.08 | 0.09 | 0.54 | 0.28, 1.04 | 0.06 |
Stroke | 0.94 | 0.73, 1.21 | 0.62 | 0.78 | 0.55, 1.10 | 0.16 |
IHD | 1.04 | 0.74, 1.49 | 0.81 | 1.15 | 0.73, 1.82 | 0.56 |
Cancer | 1.55 | 1.18, 2.05 | < 0.01* | 1.10 | 0.79, 1.55 | 0.57 |
Blood markers | ||||||
Albumin | 1.01 | 0.74, 1.39 | 0.94 | 1.31 | 0.87, 2 | 0.20 |
Hb | 0.96 | 0.92, 1.01 | 0.11 | 0.95 | 0.89, 1.01 | 0.11 |
PLT | 1 | 1, 1 | < 0.01* | 1 | 1, 1 | 0.29 |
Creatinine | 0.95 | 0.89, 1 | 0.06 | 0.94 | 0.86, 1.03 | 0.20 |
Na | 0.99 | 0.98, 1 | 0.31 | 1 | 0.98, 1.01 | 0.83 |
K | 0.73 | 0.67, 0.78 | < 0.01* | 0.82 | 0.75, 0.9 | < 0.01* |
CK | 1 | 1, 1 | 0.46 | 1 | 1, 1 | 0.43 |
Troponin I | 1 | 0.99, 1.02 | 0.96 | 1 | 0.98, 1.02 | 0.76 |
PH | 56.81 | 27.37, 122.5 | < 0.01* | 6.48 | 2.01, 21.13 | < 0.01* |
PCO2 | 0.98 | 0.98, 0.99 | < 0.01* | 0.99 | 0.99, 1 | 0.06 |
Lactate | 0.99 | 0.98, 0.99 | < 0.01* | 1 | 0.99, 1 | 0.03* |
Ca | 0.82 | 0.75, 0.91 | < 0.01* | 0.97 | 0.86, 1.09 | 0.58 |
ED treatment | ||||||
Electric shock | 0.49 | 0.34, 0.72 | < 0.01* | 0.80 | 0.44, 1.46 | 0.47 |
7% NaHCO3 | 0.20 | 0.16, 0.26 | < 0.01* | 0.17 | 0.13, 0.24 | < 0.01* |
Amiodarone | 0.40 | 0.25, 0.65 | < 0.01* | 0.47 | 0.23, 0.97 | 0.04* |
Lidocaine | 0.48 | 0.18, 1.27 | 0.14 | 1.05 | 0.31, 3.42 | 0.94 |